Package 63323-596-13

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "eb37fc8a-a264-4ce9-a130-466e9b5f3a38", "openfda": {"upc": ["0363323596033"], "unii": ["1H87NVF4DB"], "rxcui": ["310497"], "spl_set_id": ["e4be1c0e-0fe6-45a0-9229-5cde98434b84"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-596-13)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-596-11)", "package_ndc": "63323-596-13", "marketing_start_date": "20150508"}], "brand_name": "Glucagon", "product_id": "63323-596_eb37fc8a-a264-4ce9-a130-466e9b5f3a38", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Decreased GI Motility [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased Glycolysis [PE]", "Gastrointestinal Motility Inhibitor [EPC]", "Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]"], "product_ndc": "63323-596", "generic_name": "Glucagon", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glucagon", "active_ingredients": [{"name": "GLUCAGON HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "NDA201849", "marketing_category": "NDA", "marketing_start_date": "20150508", "listing_expiration_date": "20261231"}